Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous succinate is a small molecule iron supplement used primarily for the treatment and prevention of iron deficiency anemia. It works by replenishing the body's iron stores, which are essential for the production of hemoglobin—a protein in red blood cells responsible for oxygen transport throughout the body. The compound is characterized by its high bioavailability and efficacy in increasing hemoglobin levels and erythrocyte count. Ferrous succinate is typically administered orally and may be preferred in patients who cannot tolerate other forms of oral iron due to gastrointestinal side effects[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous succinate.